FKACX
Price
$27.67
Change
-$0.48 (-1.71%)
Updated
Jul 13 closing price
Net Assets
4.59B
RGEBX
Price
$81.94
Change
-$1.32 (-1.59%)
Updated
Jul 13 closing price
Net Assets
356.86B
Interact to see
Advertisement

FKACX vs RGEBX

FKACX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
FKACX vs. RGEBX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FKACX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 357B vs. FKACX (4.59B). FKACX (0.00) and RGEBX (0.00) have matching dividends . FKACX was incepted earlier than RGEBX: FKACX (27 years) vs RGEBX (12 years). FKACX (1.64) is less costly to investors than RGEBX (1.08). RGEBX is a more actively managed with annual turnover of: 32.00 vs. FKACX (27.59). RGEBX has a lower initial minimum investment than FKACX: RGEBX (250) vs FKACX (1000). RGEBX annual gain was more profitable for investors over the last year : 3.42 vs. FKACX (-15.39). RGEBX return over 5 years is better than : 12.32 vs. FKACX (-41.05).
FKACXRGEBXFKACX / RGEBX
Total Expense Ratio1.641.08152%
Annual Report Gross Expense Ratio1.641.08152%
Fund Existence27 years12 years-
Gain YTD9.3206.888135%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.59B357B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year-15.393.42-450%
Returns for 3 years-14.2836.26-39%
Returns for 5 years-41.0512.32-333%
Returns for 10 years2.8593.963%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HP33.970.64
+1.92%
Helmerich & Payne
AKA11.18N/A
N/A
aka Brands Holding Corp
LH276.68-0.13
-0.05%
Laboratory Corp
SABR1.76-0.09
-4.86%
Sabre Corp
ERNA5.54-0.52
-8.58%
Ernexa Therapeutics Inc.